ArticleJournal of experimental & clinical cancer research : CR2026
GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.
Aleksandra Adamska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.